Loss of expression of APC, or adenomatous polyposis coli, via promoter hypermethylation has been previously described in head and neck squamous cell carcinoma, bladder cancer, prostate cancer, lung cancer, and several other cancer types [31], [32], [33], [34]. The gene discussed is APC; the disease is prostate cancer.